32 studies found for:    Arnold-Chiari Malformation
Show Display Options
Rank Status Study
1 Recruiting Genetic Analysis of the Chiari I Malformation
Conditions: Syringomyelia;   Type I Arnold Chiari Malformation
Intervention:
2 Completed Establishing the Physiology of Syringomyelia
Conditions: Arnold Chiari Deformity;   Hydrocephalus;   Syringomyelia
Intervention:
3 Completed Duragen Versus Duraguard in Chiari Surgery
Condition: Chiari Malformation
Interventions: Procedure: Duraplasty with Duragen;   Procedure: Duraplasty with Duraguard
4 Recruiting A Prospective Natural History Study of Patients With Syringomyelia
Conditions: Syringomyelia;   Arnold Chiari Deformity
Intervention:
5 Active, not recruiting Magnetic Resonance Imaging (MRI) and Quantitative MR Cerebral Spinal Fluid (CSF) Flow Studies in Craniovertebral Junction Anomalies
Condition: Chiari Malformations
Intervention: Procedure: Dynamic cervical MRI
6 Recruiting Dural Graft Equivalent Comparison Trial
Condition: Chiari Malformation
Intervention: Procedure: decompression of Chiari malformation
7 Enrolling by invitation Chiari Study Looking at Use of Duragen Versus Duraguard
Condition: Chiari Malformation Type I
Intervention:
8 Recruiting Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2
Condition: Venous Leg Ulcers
Interventions: Biological: HP802-247;   Biological: Vehicle
9 Recruiting Study of the Safety and Effectiveness of Collagen Cross-Linking at an Irradiance of 9 mW/cm2 and 18 mW/cm2
Conditions: Keratoconus;   Corneal Ectasia
Interventions: Drug: Riboflavin 0.1% ophthalmic solution;   Device: CCL-VARIO UV lamp;   Device: CCL-VARIO at 18 mW/cm2
10 Recruiting NOVOCART®3D for Treatment of Articular Cartilage of the Knee
Condition: Articular Cartilage of the Femoral Condyle Between 2-6cm2
Interventions: Procedure: microfracture;   Biological: NOVOCART 3D
11 Completed Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2
Condition: Actinic Keratosis
Intervention: Drug: PEP005 Topical gel
12 Recruiting Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: LEO 43204;   Drug: Placebo
13 Completed Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis
Condition: Actinic Keratosis
Intervention: Drug: ingenol mebutate
14 Completed
Has Results
Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems
Condition: Hypogonadism
Intervention: Drug: testosterone matrix transdermal system
15 Completed Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch
Condition: Healthy
Intervention: Drug: testosterone
16 Completed Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects
Condition: Parkinson's Disease
Interventions: Drug: Rotigotine;   Other: Placebo
17 Recruiting The Genetics of Chiari Type I Malformation
Condition: Chiari Type I Malformation
Intervention:
18 Recruiting Efficacy and Safety Study of co.Don Chondrosphere to Treat Cartilage Defects
Condition: Articular Cartilage Lesion of the Femoral Condyle
Interventions: Drug: co.don chondrosphere®;   Procedure: Microfracture
19 Completed
Has Results
Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
Condition: Keratosis
Intervention: Drug: imiquimod cream
20 Completed Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects
Condition: Healthy
Intervention: Drug: Rotigotine transdermal patch

Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results
Indicates status has not been verified in more than two years